Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.


TSXV:TLT - Post by User

Comment by BudFoxx2020on Nov 06, 2023 9:46am
196 Views
Post# 35719129

RE:Excellent News

RE:Excellent NewsLooks like the LIFE financing didn't even fill the minimum required.  This offering is supposed to close on the week of Oct 30.  The offering will only close if it meets the minimum required.  I am surprised RCC didn't just fill the rest themselves.  Only 3 million dollars, for a big player like RCC, that is chump change.  I mean RCC has a price target for TLT at 0.80 cents minimum.  Wouldn't that be the easiest money ever made.  The compnay also stated that they will be working to get the pre BTD application approved over the next 6 months.  The positive here is anyone that wants to buy shares and take part in the offering can actually directly email RDW for shares.  That means you should be able to get a hold of the CEO and ask as many questions or concerns you have.  Anywys I have a feeling they will have to lower the financing prices to get it done.  It traded as low as 0.16 cents last week, so why would you go out and buy at 0.22 cents.  This is just my opinion.  Good luck all.  
<< Previous
Bullboard Posts
Next >>